BridgeBio Pharma, Inc (NASDAQ:BBIO) Receives $42 00 Average Price Target from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Research analysts at Leerink Partnrs raised their FY2023 EPS estimates for shares of BridgeBio Pharma in a research report issued to clients and investors on Wednesday, February 7th. Leerink Partnrs analyst M. Foroohar now expects that the company will earn ($3.80) per share for the year, up […]
Blueshift Asset Management LLC purchased a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 16,482 shares of the company’s stock, valued at approximately $435,000. Several other large investors have also recently made changes to […]
BMO Capital Markets assumed coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a research note published on Wednesday morning, MarketBeat reports. The firm issued a market perform rating and a $37.00 price objective on the stock. A number of other brokerages also recently issued reports on BBIO. Citigroup assumed coverage on BridgeBio […]
Moody Aldrich Partners LLC Acquires 57,639 Shares of BridgeBio Pharma, Inc (NASDAQ:BBIO) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.